2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

Communication and language skills in Huntington’s disease

Y. Manor, D. Shpunt, S. Naor, L. Frydman, A. Gad, A. Ezra, A. Migirov, J. Knaani, A. Socher, T. Gurevich (Tel-Aviv, Israel)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type

D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparative analysis of upper limb motor function and articulation disorder in Parkinson’s disease

E. Ruzicka, J. Rusz, T. Tykalova, K. Zarubova, R. Krupicka, R. Jech (Prague, Czech Republic)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder

J. Mašková, P. Dušek, D. Školoudík, K. Kupka, K. Šonka, V. Ibarburu Lorenzo Y Losada, J. Kubinyi, E. Ruzicka (Praha 2, Czech Republic)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparative study patients with different clinical forms of Parkinson’s disease

N.D. Demchuk, T.V. Yakovleva, Y.V. Karakulova (Perm, Russia)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparison of change in the UPDRS verses MDS-UPDRS in a population of Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS)

S.S. Wang, N.B. Galifianakis, M. San Luciano, P.S. Larson, P.A. Starr, N. Ziman, J.L. Ostrem (San Francisco, CA, USA)

Clinical Phenomenology and Rating Scales

12:00pm-1:30pm

Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease

W. Li, N.P. Lao-Kaim, A.A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R.A. Barker, P. Piccini (London, United Kingdom)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparison of DAT scan, cardiac MIBG scintigraphy, and cerebrospinal fluid 5HIAA levels in Parkinsonian syndrome

R. Sengoku, M. Yamazaki, D. Kaneda, Y. Nishina, A.M. Tokumaru, S. Murayama (Tokyo, Japan)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparison of mental practice and proprioceptive neuromuscular facilitation in sisters with cerebellar atrophy

C. Bedeschi, D. Guedes, D. Ambrosano (Barueri, Brazil)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease

E.J. Henderson, H. Chu, D.M. Gaunt, A.L. Whone, Y. Ben-Shlomo, V. Lyell (Bristol, United Kingdom)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2